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Abstract 
We have studied in detail the effects of the anesthetic steroid alphaxalone and its inactive analog An6-alphaxalone onthe thermotropic 
properties of model membranes using differential scanning calorimetry (DSC). The results obtained showed that, for model membranes 
from hydrated ipalmitoylphosphatidylcholine (DPPC), dioleoylphosphatidylcholine (DOPC), and egg sphingomyelin, the biologically 
active analog significantly broadened the phase transition, in contrast to the inactive one which produced only marginal effects. Also, 
alphaxalone abolished the pretransition i  these preparations whereas its AI6-analog only broadened it. However, in DPPE bilayers almost 
no differences were observed in the effects produced by the two analogs. These results suggest that the ability of the two steroids to 
perturb membranes i lipid dependent. Comparisons between the effects of the two steroids on lipid/cholesterol model membranes 
revealed that AI6-alphaxalone xcluded cholesterol from lipid/cholesterol/A|6-alphaxalone ternarysystems whereas alphaxalone 
enhanced the effects of cholesterol and reduced the cooperativity in the binary phospholipid/cholesterol system. In an attempt o 
determine whether the different hermotropic effects of the two steroids on model membranes were due to (a) differences in their ability 
to perturb the bilayers; (b) different extents of incorporation i to the bilayer, solid state 2H-NMR was applied using specifically 
deuterated steroids. The 2H-NMR data showed that alphaxalone incorporated fully into the membrane bilayer up to a molar concentration 
of 20%, while its inactive analog did only up to a concentration f 1%. To compare the abilities of the two steroids to perturb membrane 
preparations when both analogs were present in equal amounts in the membrane, the effects of very low steroid concentrations onDPPC 
bilayers were studied using DSC. The experiment showed that alphaxalone perturbed the membrane bilayers more effectively than its 
inactive analog. These results strongly suggest hat the small structural differences between the two steroids are responsible for the 
observed ifferences in their abilities to perturb membranes, possibly because of differences in the packing of these two molecules within 
the bilayers. 
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1. Introduction 
It is well known that only those steroid molecules that 
meet strict stereochemical requirements possess anesthetic 
activity. Alphaxalone (5.x-pregnan-3 a-ol- 11,20-dione) has 
potent anesthetic properties and was used clinically as the 
Abbreviations: DSC, differential scanning calorimetry; DPPC, dipal- 
mitoylphosphatidylcholine; DOPC, dioleoylphosphatidylcholine; DPPE, 
dipalmitoylphosphatidylethano]amine; NMR, nuclear magnetic resonance. 
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main active component in the commercially available anes- 
thetic Althesin. Conversely, Al6-alphaxalone (5a-pregn- 
16-en-3 t~-ol- 11,20-dione), which differs from alphaxalone 
only by having a double bond in the C-16 position (Fig. 1), 
lacks anesthetic activity [1,2]. 
To account for their structural specificities, some inves- 
tigators have suggested that anesthetic steroids act after 
binding to a distinct site on a target membrane protein [3] 
or on the GABA A receptor complex [4,5]. Alphaxalone 
was also found to enhance the binding of the GABA A 
receptor agonist muscimol to rat brain membranes at con- 
centrations of 10 -7 to l0  -5 M and to potentiate the 
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Fig. 1. Chemical structures of alphaxalone and A l°-alphaxalone. 
depolarization responses to superfused GABA or musci- 
mol on slices or rat cuneate membranes [6]. Others have 
hypothesized that the sites of action are the membrane 
lipids which are capable of a high degree of structural 
discrimination based on evidence obtained from electron 
paramagnetic resonance (EPR) experiments using spin- 
labeled bilayers containing cholesterol [7] and our own 
studies using high resolution IH-, 2H- and 13C-NMR [8- 
10]. These experiments showed that steroids possessing 
anesthetic activity had a fluidizing effect on model mem- 
branes while other structurally related but biologically 
inactive analogs produced much less disorder. O'Leary et 
al. [11] studied the effects of various anesthetic and non- 
anesthetic steroids on the DPPC bilayers using DSC and 
Raman spectroscopy. The DSC data showed that the 
steroids caused a significant depression and broadening of 
both the pretransition and the gel-to-liquid-crystal transi- 
tion. A significant correlation was also observed between 
anesthetic potency and the effects of the steroids on the 
pretransition of hydrated DPPC while Raman spectra 
showed that the steroids did not perturb the head group 
and the glycerol backbone regions. Earlier, we studied in 
our laboratory the effects of alphaxalone and Alt-alphaxa- 
lone with respect o a membrane property not involved in 
the anesthetic response, namely, the anion transport system 
in human erythrocytes [12] and found that the anesthetic 
steroid inhibited anion transport more effectively than its 
inactive analog. These experiments demonstrated that the 
differences in biological activity between the two molecules 
were not restricted to their action on neuronal membranes. 
Although, there are several reports in the literature 
regarding the effects of alphaxalone on the thermotropic 
properties of DPPC model membranes, the results are not 
always consistent with one another. Early work by Connor 
et al. [13] reported, without experimental details, that the 
incorporation of alphaxalone lowered the phase transition 
temperature (T~) of DPPC bilayers by 8 K. This effect was 
not detected by O'Leary et al. [11], who reported a lower- 
ing of the T~ value by only 0.5 K in a hydrated DPPC 
preparation containing a 10% molar concentration of al- 
phaxalone. A more detailed study in our laboratory [10] 
found that the incorporation of 17% molar alphaxalone in
DPPC bilayers significantly affected the thermotropic 
properties by lowering T c by 5 K and broadening the 
width of the main phase transition peak. However, the 
effects of alphaxalone and A~6-alphaxalone on model 
membranes from other lipids had not been previously 
examined. 
In this publication, an effort was made to resolve the 
discrepancies in the earlier DSC results by studying the 
effects of alphaxalone on DPPC bilayers under different 
equilibration conditions. The membrane ffects of the two 
steroids were also studied using other hydrated phospho- 
lipid preparations including DOPC, in which the lipid 
chains are unsaturated, egg sphingomyelin which contains 
a mixture of saturated and unsaturated fatty acid species 
and DPPE in which the headgroup is ethanolamine instead 
of choline. We also used cholesterol-containing prepara- 
tions to obtain lipid/steroid/cholesterol ternary systems. 
To measure the extent of incorporation of alphaxalone 
and A~6°alphaxalone in DPPC bilayers we used solid state 
2H-NMR spectroscopy. The results allowed us to more 
carefully evaluate the factors which determine the ob- 
served differences between the two steroids with regard to 
their abilities to perturb membrane bilayers. They also 
allowed us to distinguish between those effects which can 
be attributed to differences in the amounts of steroid 
incorporated into the bilayer from those due to the steroid's 
conformational properties [9]. 
2. Materials and methods 
2.1. Materials 
DPPC, DOPC, DPPE and egg sphingomyelin were 
obtained from Avanti Polar Lipids, Birmingham, AL. Ac- 
cording to the chromatographic data provided by the com- 
pany, egg sphingomyelin was a mixture of several species 
containing saturated (14:0, 16:0, 18:0, 20:0, 22:0, 24:0) 
and unsaturated (18:1, 22:1, 24:1) acyl residues, the major 
component being the palmitoyl residue which constituted 
77% of the mixture. Alphaxalone and Alt-alphaxalone 
were kindly donated by Glaxo Group Research, Middle- 
sex, UK. 
2.2. Methods 
Sample preP2aration procedures were identical for DSC 
and solid state H-NMR experiments. Appropriate amounts 
of phospholipid and protonated or deuterated steroids (with 
or without cholesterol) were dissolved in spectroscopic 
grade chloroform. The solvent was then evaporated by 
passing a stream of O2-free nitrogen over the solution at 
50°C and the residue was placed under vacuum (0.1 mmHg) 
for 12h. 
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For DSC experiments, distilled and deionized water was 
added to the dried mixtures (ca. 5 mg) to produce a 50% 
(w/w) lipid/water preparation. The sample was then 
placed in a stainless slleel capsule (Perkin-Elmer) and 
sealed hermetically and thermograms were obtained on 
Perkin-Elmer DSC-2 and DSC-7 instruments. The 
calorimeter temperature scale was calibrated using stan- 
dard samples such as fully hydrated DPPC and pure 
crystalline indium. To ensure complete quilibration, the 
sample was held at a temperature above its phase transition 
temperature for 5 min prior to scanning. Furthermore, ach 
sample was scanned at least twice until identical thermo- 
grams were obtained. We found that the optimal scanning 
rate is 2.5 K/rain, as higher or lower scanning rates 
produced some distortions in the thermograms. Being aware 
that the method of sample preparation can significantly 
affect the appearance of the thermogram, we used for our 
comparisons thermogranls from samples prepared in an 
identical manner and having an identical thermal history. 
For the solid state 2H-NMR, the dried mixture (ca. 150 
mg) was introduced into a 7 mm glass tube and hydrated 
using deuterium-depleted water to produce a 50% (w/w) 
lipid-water preparation, cooled in liquid nitrogen and sealed 
under high vacuum. Solid state 2H-NMR spectra were 
obtained (at 55.2 MHz) using a 900-T-90y quadrupole echo 
sequence [14] with a 90 ° pulse width of 2.1 to 2.4 /zs, a 
pulse separation (z) of 4.0 /~s and a dwell time of 3.5 /zs. 
Recycle delay was 0.2 s, and up to 16000 echoes were 
accumulated for each Sl~ectrum. 
3. Results and discussion 
3.1. Effect of equilibration conditions on the thermotropic 
properties of DPPC + a,!phaxalone 
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Fig. 2. Normalized thermogram of DPPC bilayer without steroid and 
thermograms of DPPC bilayers containing alphaxalone (x = 0.20) ob- 
tained (A) right after sealing; (B) second run; (C) third run; (D) after 
leaving at room temperature for 5 days; (E) after leaving in the freezer for 
5 additional days. 
Our first goal was to reconcile the apparent inconsisten- 
cies 'in the thermotropic data of different laboratories ob- 
tained from DPPC bilayer samples containing alphaxalone 
and we hypothesized that this was due to differences in the 
thermal histories of the samples. To explore this possibility 
we subj.ected a DPPC/alphaxalone preparation with a 
molar ratio of 80:20 (x= 0.20) to different equilibration 
conditions, before performing a series of DSC experi- 
ments. Fig. 2 shows a thermogram from a pure DPPC 
bilayer preparation aad five thermograms from a 
DPPC/alphaxalone prelgaration run at different stages of 
equilibration. When the sample was run immediately fol- 
lowing hydration, the phase transition temperature was 
about 5 to 8 K below that of DPPC (To = 41.2°C). For 
example, T~ was 33°C in the first run and increased to 
35°C by the third run. Other subsequent scans gave identi- 
cal thermograms to thai: obtained in the third run. These 
results were in agreement with the results obtained by 
Connor et al. [13] and ourselves [10] where it was reported 
that the presence of alphaxalone in DPPC bilayers reduced 
the phase transition temperature by 8 K and 4-5 K, 
respectively. When the sample was kept at room tempera- 
ture for 5 days the thermogram had a T~ at 40°C, only 
about 1 K below that of pure DPPC. We also found that 
when the sample was left in the freezer for an additional 5
days it showed a T c of 41°C, perhaps explaining the results 
reported earlier by O'Leary et al. [11]. 
As can be seen in Fig. 2, the lineshapes of the thermo- 
gram vary depending on equilibration time and tempera- 
ture. Generally, the observed broadening of the principal 
phase transition produced by alphaxalone diminished with 
longer equilibration times, while the enthalpy change (AH) 
remained constant throughout the thermal history. 
3.2. Effects of the two steroids on the thermotropic proper- 
ties of model membranes. Lipid dependent variations of 
DPPC, DOPC, sphingomyelin a d DPPE 
To gain a better understanding on the specificity of the 
steroid-membrane i teractions, we studied the effects of 
260 T. Mavromoustakos et al. / Biochimica et Biophysica Acta 1239 (1995) 257-264 
DPPC 
_. . .~+ a lphax .~ ~-  
' ' ' 3's ;o  ' ' ' '~ ~' ' 'o 20 25 30 45 45 50 5 0 65 7 
TEMPERATURE ('C) TEMPERATURE (=C) 
I-- 
O 
Z LU 
Fig. 3. Normalized thermograms of model membrane preparations of 
DPPC (left traces) and DPPE (right traces). Top traces: lipid bilayer 
alone; middle traces: containing alphaxalone (x = 0.20); bottom traces: 
containing Atlf-alphaxalone (x = 0.20). 
the two steroids on the thermotropic properties of model 
membranes prepared from different phospholipids using 
DSC (Figs. 3 and 4). We found that all membranes 
prepared from phospholipids possessing choline head- 
groups were affected very differently by each of the two 
steroids. However, neither steroid had any significant ef- 
fect on hydrated DPPE preparations. 
In the DPPC preparation, alphaxalone (x = 0.20)pro- 
duced a significant broadening of the main transition which 
seemed to be composed of two overlapping components 
while the pretransition was no longer discernible (Fig. 3, 
left). This broadening of the main transition was inter- 
preted as decreased cooperativity at the phase transition. 
Conversely, the inactive A16-alphaxalone did not affect he 
half width and T c of the main transition of the hydrated 
DPPC preparation; only the pretransition was broadened 
and appeared at a lower temperature. 
The effects of the two steroids on DOPC bilayers were 
strikingly different (Fig. 4, left). Alphaxalone produced a
dramatic broadening of the phase transition as manifested 
by the appearance of two transition maxima, a phe- 
nomenon which may be attributed to a phase inhomogene- 
ity in the model membranes caused by the presence of the 
steroid [14,15]. This may, in turn, reflect he existence of 
two domains each represented by one peak in the thermo- 
gram. Thus, the peak on the right may be due to a DOPC 
domain containing a low concentration of alphaxalone 
while the peak on the left may represent a DOPC domain 
with a high concentration f the steroid. A'6-Alphaxalone 
had almost no effect on the thermograms of DOPC bilay- 
ers. Distinct differences were also observed between the 
effects of the two analogs on egg sphingomyelin prepara- 
tions (Fig. 4, right). Alphaxalone lowered the phase transi- 
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Fig. 4. Normalized thermograms of model membrane preparations of 
DOPC (left traces) and egg sphingomyelin (right traces). Top traces: lipid 
bilayer alone; middle traces: containing alphaxalone; bottom traces: con- 
taining Alf-alphaxalone. Steroid concentrations: x= 0.20 in DOPC 
preparations and x = 0.10 in egg sphingomyelin preparations. 
tion temperature and broadened it significantly, whereas 
Al6-alphaxalone once again produced almost no effect. 
Unlike the membrane preparations from phospholipids 
with choline headgroups, DPPE preparations were very 
marginally affected by the presence of each of the two 
steroids giving almost identical thermograms with that 
from the pure lipid and showing no changes in their 
transition temperatures and peak widths. This may be the 
result of very limited or no incorporation (Fig. 3, right) of 
the steroids into hydrated DPPE. 
It is evident from the above experiments hat the effects 
of the two steroids on model membranes are highly depen- 
dent on the nature of the phospholipid used in the prepara- 
tion. Although it is difficult to fully explain these differ- 
ences using molecular arguments, ome correlation seems 
to exist between the thermotropic effects induced by the 
steroid on the membrane and the extent of phospholipid 
hydration; the more hydrated the phospholipid the more 
susceptible it is to perturbation by the steroids. Thus, the 
most hydrated unsaturated choline phospholipid (DOPC) 
experiences the greatest perturbation by alphaxalone fol- 
lowed by the less hydrated DPPC [16-18]. DPPE is the 
least hydrated [ 19] of the phospholipids used in our study 
and is only marginally affected by the steroids. 
3.3. DPPC, DOPC and DPPE bilayers containing choles- 
terol 
Fig. 5 depicts the effects of the two steroids on DPPC 
model membranes containing two different molar ratios of 
cholesterol x = 0.08 (left) and x = 0.20 (right). The ther- 
mogram from the x = 0.08 cholesterol preparation shows a 
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Fig. 5. Normalized thermograms of model membrane preparations of 
DPPC+cholesterol with cholesterol concentrations of x = 0.08 (left 
traces) and x = 0.20 (right traces). Top traces: lipid + cholesterol bilayer 
alone; middle traces: with additional alphaxalone (x=0.20) ;  bottom 
traces: with additional A If-alphaxalone (x = 0.20). 
sharp peak centered at 38.5°C. When the cholesterol con- 
centration is increased to x = 0.20, this peak is now 
broadened and has a smaller area indicating that the en- 
thalpy change associated with the gel to liquid crystal 
phase transition is reduced. These results are consistent 
with a previous detailed study related to the thermotropic 
behaviour of the DPPC/cholesterol bilayers in which 
cholesterol [20] was shown to reduce the cooperativity 
between the lipids in the membrane, thus, serving as a 
buffer to temperature changes near the phase transition. 
The addition of alphaxalone (x = 0.20) to the DPPC + 
cholesterol (x = 0.08) preparation transforms the sharp 
component of the thermegram into a broad phase transition 
while a new sharper component appears around T c = 36°C. 
Conversely, A16-alphaxalone causes less significant broad- 
ening of the transition and does not lower the phase 
transition temperature. Addition of alphaxalone to the 
DPPC preparation with the higher cholesterol content (x = 
0.20) almost completely eliminates the endotherm peak 
associated with the phase transition, a reflection of the 
severe effect it has on chain cooperativity. The effects of 
A16-alphaxalone on the same preparation are much less 
striking and involve only broadening of the endotherm but 
no change in the phase transition temperature. 
Fig. 6 depicts the thennotropic effects of the two steroids 
on the DOPC/cholesterol (x = 0.20) preparation which, in 
the absence of drug, shows a broad phase transition T c = 
-26.8°C. Addition of alphaxalone (x=0.20)  to this 
preparation broadens this transition which now appears as 
an endotherm with two peaks, suggesting the existence of 
two domains. The peak on the right has the same Tc as the 
parent preparation and probably represents a 
DOPC/cholesterol domain, while the peak on the left is 
due to another domain composed of DOPC, cholesterol 
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Fig. 6. Normalized thermograms of model membrane preparations of 
DOPC+cholesterol with cholesterol concentrations of x = 0.20 (left 
traces) and x = 0.35 (right traces). Top traces: lipid + cholesterol bilayer 
alone; middle traces: with additional alphaxalone (x= 0.20); bottom 
traces: with additional AJf-alphaxalone (x = 0.20). 
and alphaxalone. Again Al6-alphaxalone has a different 
effect on this membrane preparation. However, unlike the 
marginal changes produced by this steroid on the thermo- 
grams of other membrane preparations, we now observe an 
upward shift of about 4 K in the T c. A closer examination 
of the DOPC/cholesterol//t~6-alphaxalone thermogram 
reveals that it resembles the one obtained from the pure 
DOPC preparation (Fig. 4). This leads us to the conclusion 
that the steroid excludes much of the cholesterol from the 
bilayers by complexing with it and forming a different 
domain which does not significantly affect the ther- 
motropic properties of the hydrated DOPC system. Similar 
results were obtained with preparations containing higher 
concentrations of cholesterol (x = 0.35) (Fig. 6). These 
results are reminiscent of earlier data [21] with DMPC 
preparations in which we first postulated the formation of 
a A~6-alphaxalone-cholesterol complex. 
Fig. 7 shows the effects of the two steroids on 
DPPE/cholesterol (x = 0.20) preparations. The thermo- 
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Fig. 7. Normalized thermograms of hydrated (A) DPPE + cholesterol 
x = 0.20 (top trace), (B) with additional alphaxalone x = 0.20 (middle 
trace) and (C) with additional ,~ll6-alphaxalone x = 0.20 (bottom trace). 
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grams appear to follow a similar trend as those from the 
other cholesterol containing samples. The initial sample 
has a very broad phase transition which is further broad- 
ened and ~ifted to a lower temperature by the addition of 
alphaxalone. Conversely, the biologically inactive Al6-ana- 
log signifuzantly sharpens the phase transition and shifts it 
to a higher temperature. The thermogram now resembles 
the one obtained from a DPPE preparation without choles- 
terol (Fig. 3) and again suggests displacement of choles- 
terol from the bilayer through the formation of a A16-al - 
phaxalone-cholesterol complex. 
Interestingly, we find that Al6-alphaxalone displaces 
cholesterol more effectively in hydrated phosphatidyl- 
ethanolamine than phosphatidylcholine preparations. This 
trend is not observed with alphaxalone which produces 
analogous effects on the different cholesterol-containing 
bilayers as those observed with preparations containing no 
cholesterol. 
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Fig. 8. Solid state 2H-NMR spectra from hydrated DPPC bilayer prepara- 
tions containing (9,12a,12fl,17,21,21,21-d7)-alphaxalone or 
(9,12ot.12fl,21,21,21-d6)-AJ6-alphaxalone ( =0.01, 0.05 and 0.10). 
Left: experimental d ta. Right: simulated spectra. 
3.4. The molecular mechanism of bilayer perturbation by 
anesthetic steroids 
The observed differences between a~phaxalone and 
A16-alphaxalone in their abilities to affect he thermotropic 
properties of model membranes can be attributed to one of 
two causes or a combination of the two. The first of these 
is the difference in the amounts of each of the two steroids 
in the bilayer with alphaxalone appearing to incorporate 
more effectively than its A16-congener. The second reason 
is associated with the steroid's ability to pack properly 
within the membrane bilayers, a property which is highly 
sensitive to the stereoelectronic features of this molecule. 
As we proposed in earlier publications [8,9], imperfect 
packing of the lipid chains is associated with conforma- 
tional and dynamic hanges in the chain segments. These 
effects, which are observed as characteristic changes in the 
thermograras of the bilayer preparation, can be described 
generically as 'membrane perturbation'. A good example 
of a membrane-perturbing steroid is alphaxalone whose 
D-ring protrudes from the plane of the other three. This 
results in imperfect packing within a variety of phospho- 
lipid bilayers. Conversely, the biologically inactive, A 16- 
alphaxalone has all four rings coplanar, packs better and 
produces no significant perturbation. To dissect hese two 
factors which may be responsible for membrane perturba- 
tion by steroids or other membrane-active molecules, 
namely, (a) the degree of incorporation and (b) the packing 
characteristics of the ligands in the bilayer, we used a 
combination of solid-state 2H-NMR and DSC. 
3.5. Extent of incorporation of the steroids in DPPC 
bilayers 
Solid-state 2H-NMR was used as the method of choice 
for obtaining direct information on the amount of the 
steroid present within the bilayer. In such an experiment 
which is conducted on a stationary sample, the spectrum 
due to the 2H-labeled steroid is expected to appear either 
as a relatively narrow singlet if the steroid is present in 
solution undergoing isotropic motions or as a characteristic 
Pake pattern, if the steroid is embedded in the anisotropic 
environment of the bilayer [22]. 
Fig. 8 on the left, depicts typical solid state 2H-NMR 
spectra of DPPC bilayer preparations containing deu- 
terium-labelled alphaxalone and Al6-alphaxalone at42°C, 
each in three different concentrations (x = 0.10, 0.05, and 
0.01). To standardize our measurements, weused the same 
amount of DPPC in each of the samples. Furthermore, the 
spectra were obtained using identical experimental parame- 
ters, thus allowing us to correlate spectral intensities with 
the amount of drug incorporated in the bilayer. Because of 
their very limited solubility in water, the steroids do not 
exist in any significant amount dissolved in the aqueous 
phase of the membrane preparation. Therefore, they are 
expected either to intercalate between the chains of the 
hydrated phospholipid or, alternatively, to form solid ag- 
gregates which segregate outside of the bilayer. Under the 
experimental conditions used, the observed spectrum is 
solely due to the population of steroid molecules which is 
incorporated in the bilayer, since those molecules present 
in the solid phase do not significantly contribute to the 
2 H-spectrum. 
In all of the spectra, the central doublet is due to the 
-COCD 3 group in the 17-position and is used as a measure 
of incorporation of each of the two steroids. The spectra 
from the alphaxalone-containing preparations also include 
two wider and less intense doublets due to other deuterons 
on the steroid ring which have only partially exchanged 
with the respective protons. 
We are able to quantitatively evaluate the spectral areas 
under each of the narrow doublets using spectral simula- 
tions as can be seen on the right in Fig. 8. A more 
expanded solid-state 2H-NMR study which will include a 
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Fig. 9. Normalized thermograms of model membrane preparations of DPPC containing steroids with low concentrations of x = 0.001 (left traces) and 
x = 0.01 (right traces). Top traces: lipid bilayer alone; middle traces: DPPC + alphaxalone; bottom traces: DPPC + Al6-allphaxalone. 
large number of steroid molecules will be described else- 
where and will give a more detailed account of the meth- 
ods and experimental conditions used in this experiment. 
The 2H-spectra from the inactive Al6 -ana log  show a 
much less intense narrow doublet, an indication of poor 
incorporation of the steroid in the bilayer. All three spectra 
are of nearly equal intensity indicating that at a concentra- 
tion of x = 0.01 saturation had already occurred. Addition- 
ally, the spectral quantil~ttion allowed us to estimate that at 
a steroid concentration of x = 0.01 both steroids incorpo- 
rated nearly equally. 
3.6. Effects of low steroid concentrations on hydrated 
DPPC bilayers 
Having determined by an independent method the con- 
centration limit below which both steroids incorporate 
equally into the DPPC bilayers, we were now able to 
design an experiment tl~ough which the steroid's ability to 
perturb the model membrane could be studied and corre- 
lated with its molecular features and its packing properties 
in the bilayer. The experiment involved the use of DSC to 
observe the thermotropic properties of DPPC bilayer 
preparations containing low steroid concentrations (_< 
0.01). 
Fig. 9 depicts two sets of thermograms corresponding to 
preparations with x -- 0.01 and x = 0.001 steroid concen- 
trations. Changes in the main transition are not easily 
discernible at the low steroid concentrations. However, 
such differences can be observed clearly at the pretransi- 
tion endotherm of the different DPPC preparations. 
At the higher steroid concentration of x---0.01 the 
differences between the thermal pretransitions of the two 
preparations are even starker with the alphaxalone-contain- 
ing preparation having a considerably broader pretransi- 
tion. 
The above experiment demonstrates that when incorpo- 
rated equally in a membrane system, the two steroids exert 
very different effects on the conformational nd dynamic 
properties of the bilayer. The data clearly indicate that 
alphaxalone perturbs the membrane bilayer system more 
effectively than its i nac t ive  Al6-analog. This observation 
lends support o the hypothesis according to which the 
ability of membrane-active compounds to perturb mem- 
branes is closely linked to imperfect packing of these 
molecules in the bilayer. 
4. Conclusions 
(1) The anesthetic steroid alphaxalone affects the ther- 
motropic properties of membrane preparations from DPPC, 
DOPC and sphingomyelin more effectively than its bio- 
logically inactive analog A16-alphaxalone. However, both 
steroids do not significantly perturb hydrated DPPE prepa- 
rations. Some correlation may exist between the extent of 
hydration of the phospholipid polar group and the degree 
to which the membrane preparation is affected by mem- 
brane-active steroids. 
(2) Alphaxalone incorporates relatively easily within 
membrane-bilayers. However, the degree of incorporation 
can be greatly affected by the equilibration conditions. 
Conversely, Al6-alphaxalone incorporates in membrane 
bilayers sparingly, a property which may be related to the 
low solubility of this steroid in organic solvents presum- 
ably because of tight intermolecular packing in its solid 
state. 
(3) At concentrations which are low enough to allow 
both steroids to be fully incorporated in DPPC model 
membranes, alphaxalone perturbs the bilayers more effec- 
tively than Al6-alphaxalone. This difference can be ex- 
plained by invoking an imperfect packing of alphaxalone 
264 T. Mavromoustakos et al. / Biochimica et Biophysica Acta 1239 (1995) 257-264 
within the membrane r sulting in changes in the conforma- 
tional and dynamic properties of the bilayer chains. Con- 
versely, A~6-alphaxalone does not significantly affect the 
packing of the lipid chains in the bilayer and perturbs the 
membrane minimally. 
(4) Alphaxalone perturbs membranes more effectively 
than its Al6-congener because of (a) better incorporation 
into the bilayer (b) its ability to induce conformational and 
dynamic hanges in the bilayer chains. We can postulate 
that perturbation of the membrane lipids by alphaxalone 
may affect the functional properties of one or more mem- 
brane-associated proteins and explain its anesthetic proper- 
ties. 
(5) In cholesterol-containing membrane bilayers Al6-al- 
phaxalone forms cholesterol/A16-alphaxalone complexes 
thus, effectively reducing the concentration f cholesterol 
within the bilayer. Alphaxalone does not form such com- 
plexes but reduces the cooperativity during the phase 
transition in the phospholipid/cholesterol system. It is 
unclear whether the above differences in how the two 
steroids interact with phospholipid/cholesterol mixtures 
are relevant to their physiological properties. 
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